Chad Hooper joined Biospring Partners as an Operating Partner from Biospring portfolio company Kiniciti, where he served as VP, Corporate Development. Chad also works with Abzena, CenExel and currently serves on the Board of Cedar Health.
Chad has spent the last decade supporting industry-leading pharma services companies, with a focus on corporate development activities, including leading mergers and acquisitions and investments, driving partnerships, and establishing and executing multi-year growth strategies. Chad most recently served the clinical research group of Thermo Fisher Scientific as Vice President, Corporate Development and Strategy, joining that business as part of the acquisition of PPD Inc., a leading clinical research organization (CRO). Prior to PPD, Chad served in a similar capacity at Patheon Inc., a leading global CDMO.
Chad is a graduate of the University of North Carolina at Chapel Hill and began his career in investment banking at Truist (formerly SunTrust Robinson Humphrey) and Piper Sandler (formerly Edgeview Partners).
